Eisai’s Approach To the New Alzheimer’s Drug
Financial Times interviewed Dr. Keith Vossel about his perceptions of treating Alzheimer’s patients with lecanemab.
Related Articles
Article
UCLA Develops New Alzheimer's Disease Therapeutic
Dr. Varghese John, Dr. Istvan Mody, and colleagues were highlighted in a UCLA article about their recent therapeutic development, targeting ...
1 min read
Article
Healthy Body. Healthy Mind.
In the Summer Edition of Keiro Connect, Dr. Kevin Bickart discussed physical activity, including dancing, to improve brain health and prevent dementia ...
1 min read
Article
A More Inclusive Framework for Alzheimer’s Disease
The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...
1 min read
Article
An In-Depth Interview on Various Neurodegenerative Diseases
Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...
1 min read